Table 3:
VAT HU | P value | SAT HU | P value | |
---|---|---|---|---|
Baseline* | ||||
Adiponectin (μg/mL) | 0.11 | 0.14 | −0.21 | 0.007 |
CRP (mg/L) | −0.10 | 0.22 | 0.03 | 0.72 |
PAI-1 Activity (IU/mL) | −0.02 | 0.81 | 0.10 | 0.23 |
TPA Activity (IU/mL) | 0.17 | 0.03 | −0.10 | 0.20 |
HOMA-IR | 0.12 | 0.02 | 0.21 | <0.001 |
IGF-1 (ng/mL) | −0.05 | 0.31 | −0.04 | 0.41 |
Change in VAT HU | P value | Change in SAT HU | P value | |
26-week change** | ||||
Adiponectin (μg/mL) | 0.19 | 0.02 | 0.18 | 0.02 |
CRP (mg/L) | 0.04 | 0.57 | 0.11 | 0.15 |
PAI-1 Activity (IU/mL) | −0.05 | 0.50 | −0.02 | 0.83 |
TPA Activity (IU/mL) | 0.06 | 0.42 | 0.03 | 0.69 |
HOMA-IR | −0.02 | 0.73 | 0.02 | 0.69 |
IGF-1 (ng/mL) | 0.09 | 0.08 | 0.14 | 0.01 |
Adjusted for baseline AT area
Adjusted for change in AT area
CRP=C-reactive protein, PAI-1=plasminogen activator inhibitor, IU=international units, TPA=tissue plasminogen activator, HOMA-IR=homeostatic assessment model assessment of insulin resistance, IGF-1=insulin-like growth factor-1, VAT=visceral adipose tissue, SAT=subcutaneous adipose tissue, HU=Hounsfield Units